MaxCyte IPO Presentation Deck

Proprietary Flow Electroporation Technology for Cell Engineering July 2021 Any Cell Any Molecule Primary cells Stem Cells (iPSCS) Insect cell lines lon channels GPCRs Transporters Receptors CRISPR/CAS9 . • Immortalized mammalian cell lines Mammalian cancer cell lines Hematopoietic cells TALENS siRNAS/ASOs Nucleases Enzyme reporters • Transcription factors Epigenetic regulators . Antibodies Lentivirus/AAV Bi-specifics Alphavirus Adenovirus VLPS Subunit vaccines Fusion proteins Antigens CONFIDENTIAL APPLICATIONS OF ENGINEERED CELLS GO 国 Cell therapy Transient protein production Vaccines and viral vectors Stable expression Small molecule discovery M MaxCyte 27

View entire presentation